Antiprotozoal and antimicrobial drug, a derivative of 5-nitroimidazole. The mechanism of action is the biochemical reduction of the 5-nitro group of metronidazole by intracellular transport proteins of anaerobic microorganisms and protozoa. The reduced 5-nitro group of metronidazole reacts with the DNA of a cell of microorganisms, inhibiting the synthesis of their nucleic acids, which leads to the death of bacteria.
Active in a relationship Trichomonas vaginalis, Gardnerella vaginalis, Giardia intestinalis, Entamoeba histolytica, Lamblia spp., as well as obligate anaerobes Bacteroides spp. (incl. Bacteroides fragilis, Bacteroides distasonis, Bacteroides ovatus, Bacteroides thetaiotaomicron, Bacteroides vulgatus), Fusobacterium spp., Veillonella spp., Prevotella (Prevotella bivia, Prevotella buccae, Prevotella disiens) and some Gram-positive microorganisms (Eubacteria spp., Clostridium spp., Peptococcus spp., Peptostreptococcus spp., Mobiluncus spp.).
To Metronidazole insensitive aerobic microorganisms and facultative anaerobes, but in the presence of mixed flora (aerobes and anaerobes) metronidazole acts synergistically with antibiotics effective against conventional aerobes.
With external application also has antioxidant, anti-inflammatory and dermatoprotective effect.
Has anti-acne action, the mechanism of which is precisely unknown (not related to the action on the mite Demodex folliculorum, found in the hair follicles and the secretion of the sebaceous glands, and any influence on the production of this secret).
Antioxidant activity is due to a significant decrease in production by neutrophils, which are potential oxidants, capable of causing tissue damage at the site of inflammation.
Metronidazole for external use is ineffective against telangiectasias seen in rosacea.